Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - aġenti antineoplastiċi - rydapt huwa indikat:f'kombinazzjoni mal-istandard daunorubicin u cytarabine induzzjoni u doża għolja ta ' cytarabine konsolidazzjoni kimoterapija, u għall-pazjenti fil-rispons sħiħ segwit minn rydapt waħidha-manutenzjoni tal-kura, għall-pazjenti adulti li jkunu għadhom kif ġew dijanjostikati lewkimja majelojde akuta (aml) li huma flt3 mutazzjoni pożittivi (ara sezzjoni 4. 2);bħala monoterapija għall-kura ta ' pazjenti adulti b'aggressiva sistemika mastocytosis (asm), sistemika mastocytosis assoċjati mal-ematoloġiċi neoplażmi (sm ahn), jew tal-mast cell li lewkimja (mcl).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zoetis belgium sa - ċirkovirus tal-ħnieżer-vaċċin (inattivat, rikombinanti) - immunologicals for suidae, inactivated viral vaccines - Ħnieżer (għall-tismin) - għall-immunizzazzjoni attiva tal-ħnieżer mill-età ta ' 3 ġimgħat kontra l-virus porcine circovirus tip 2 (pcv2) biex titnaqqas it-tagħbija virali fid-demm u fit-tessuti linfojde u l-ippurgar jixħtu kkawżati mill-infezzjoni bil-pcv2.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

laboratorios hipra, s.a. - eimeria acervulina, razza 003, eimeria maxima, razza 013, eimeria mitis, razza 006, eimeria praecox, razza 007, eimeria tenella, razza 004 - parassiti ħajjin, il-vaċċini immunoloġiċi għall-aves - chicken - għal-immunizzazzjoni attiva tal-flieles mill-1 ta'kuljum ta'l-età biex jitnaqqas intestinali leżjonijiet u oocysts-produzzjoni assoċjati mal-koċċidjożi kkawżata mill-eimeria acervulina, eimeria maxima, eimeria mitis, eimeria praecox u l-eimeria tenella u biex tnaqqas sinjali kliniċi (dijarea) assoċjata mal-eimeria acervulina, eimeria-limiti massimi u eimeria tenella.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - klieb - għat-trattament ta mhux resectable, mhux metastatiku (li waqfien) taħt il-ġilda it-tumuri tal-mast cell li jinsabu fil jew distali l-minkeb jew l-hock, u mhux resectable, mhux metastatiku tal-ġilda tumuri tal-mast cell fil-klieb.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - ażma - mediċini għall-imblokkar tal-passaġġ tan-nifs mard, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunoloġiċi għal suidae - Ħnieżer (għall-tismin) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

biomarin international limited - vosoritide - achondroplasia - drogi għat-trattament ta 'mard tal-għadam - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karċinoma, pulmun mhux taċ-Ċellula Żgħira - aġenti antineoplastiċi - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

vétoquinol sa - emodepside, praziquantel, tigolaner - anthelmintics, - qtates - for cats with, or at risk from, mixed parasitic infestations. the veterinary medicinal product is exclusively indicated when ectoparasites, cestodes and nematodes are targeted at the same time.